Therapeutic potential of modified Yukgunja-tang (Liujunzi Decoction, Rikkunshito) as an adjuvant treatment for lung cancer: a systematic review and meta-analysis.

Front Pharmacol · 2025 · PMC12522206 · PMID 41104332

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

marginally significantp = 0.02actually significant

The modified YGJT group showed a marginally significant reduction in myelosuppression compared to the control group (RR 0.63, 95% CI: 0.43–0.92, p = 0.02) ( Figure 8A ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.